investors.kannalife.comNeuropathix, Inc. – A Phyto-Medical Company | Developing Pharmaceuticals to Protect the Brain

investors.kannalife.com Profile

Investors.kannalife.com is a subdomain of kannalife.com, which was created on 2010-05-09,making it 14 years ago.

Description:KannaLife Sciences, Inc. is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as...

Keywords:#6630507, 6630507, USPATENT6630507, phyto, medical, pharmaceutical, biotechnology, botanical,...

Discover investors.kannalife.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

investors.kannalife.com Information

HomePage size: 50.656 KB
Page Load Time: 0.570315 Seconds
Website IP Address: 104.154.134.76

investors.kannalife.com Similar Website

Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP)
ir.cnspharma.com
Mirum Pharmaceuticals, Inc. - Investor Relations
ir.mirumpharma.com
PHYTO - International - The power of botanics
en.phyto.com
Brain Exercises, Brain Training, Brain Health – BrainHQ from Posit Science
aarp.brainhq.com
Ironwood Pharmaceuticals, Inc. - Company Overview
investor.ironwoodpharma.com
ISH Data :: Allen Brain Atlas: Mouse Brain
mouse.brain-map.org
McKesson | Medical Supplies, Pharmaceuticals Healthcare Solutions
sites.mckesson.com
Picture Book Brain Trust - Picture Book Brain Trust
trust.picturebookbrain.com
Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC
lifelinepharm.tracktracerx.com
Total Brain Blog - Self Monitoring and Self Care Brain Optimization Platform
blog.totalbrain.com
IEEE Brain | Neuroscience News, Events, and Research – IEEE Brain Initiative
brain.ieee.org
NeuroNation - The Blog about Brain Training & Brain
blog.neuronation.com

investors.kannalife.com PopUrls

Developing Pharmaceuticals to Protect the Brain: Neuropathix ...
https://investors.kannalife.com/
Kannalife, Inc. Appoints Dr. Tage Honoré as Chairman of the Company's ...
http://investors.kannalife.com/prviewer/release_only/id/4458916
Kannalife, Inc. Bolsters IP Portfolio with Multiple Patents Issued in ...
https://investors.kannalife.com/prviewer/release_only/id/4370998
Neuropathix, Inc. - A Phyto-Medical Company | Developing ...
https://investors.kannalife.com/KLFE/stock_quote
Kannalife, Inc. Receives Seventh Patent by Extending Patent Family to ...
http://investors.kannalife.com/prviewer/release_only/id/4264362
Kannalife Inc. Publishes New Research on Chemotherapy-Induced ...
http://investors.kannalife.com/prviewer/release_only/id/3824234
Kannalife, Inc. Receives Patent Grants in Additional European Territories
http://investors.kannalife.com/prviewer/release_only/id/4433704
Kannalife, Inc. CEO Featured in OTCQB Podcast Discussing KLS-13019 and ...
http://investors.kannalife.com/prviewer/release_only/id/4292466
Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark ...
http://investors.kannalife.com/prviewer/release_only/id/4278031
PDF Financial Tearsheet
https://investors.kannalife.com/template_files/1360/tearsheet_pdf.pdf
Kannalife Spokesman Nick Lowery Wins 2018 CNBC Stock Draft
http://investors.kannalife.com/prviewer/release_only/id/3607310

investors.kannalife.com Httpheader

Server: nginx
Date: Tue, 14 May 2024 22:38:31 GMT
Content-Type: text/html
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding, Accept-Encoding
Set-Cookie: ci_session=T8BmeK2B%2FO4alHQgmEuJan%2BhriLPOnp74tjCKkoqENrdjZXOTU%2FxnIUmb%2BddOMqHgBLDF31iUyZJpCnumK9O5pW7rRQlbbmkL%2FiS7UxyMRAM%2BFVUhNds6fNfuEOVEeQpUn55rm0mavMvmijMmRuvT1rVHNhxhxOJWDailf%2BNxgyrpRof4k3Ai%2FyB0I1CCWIpwmjedW7EP4HrgH35MN%2FUfdkha0PInvXd1OcNDlWYMkKJvC7ottjqJTldYCOGvJDNvvrhElQIkEGg8RrBCm2UPFGUQl3UR1zQywE41TPrKjOz%2BfDVS4eZcVYQZ6RZSZziwiDXj5ofVGnew1QJTsrdTg%3D%3D; expires=Wed, 15-May-2024 00:38:31 GMT; path=/
Expires: Tue, 14 May 2024 22:38:31 GMT
Last-Modified: Tue, 14 May 2024 22:38:31 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
X-Request-ID: b1fad446bf8d599b53d070b02a053db8
X-Cache: EXPIRED

investors.kannalife.com Meta Info

charset="utf-8"/
content="width=device-width" name="viewport"/
content="KannaLife Sciences, Inc. is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of U.S. Patent 6,630,507, Cannabinoids as Antioxidants and Neuroprotectants (the 507 Patent). KannaLife is currently conducting research and development at the Bucks County Biotechnology Center in Doylestown, PA, for a target drug candidate to treat Hepatic Encephalopathy (HE). HE is an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain. #6630507, 6630507" name="description"
content="#6630507, 6630507, USPATENT6630507, phyto, medical, pharmaceutical, biotechnology, botanical, medicine, cannabis, cannabinoids, endocannabinoids, antioxidants, neuroprotectants, phytocannabinoids, phytopharmaceutical, terpene, terpenes, cannatol, kannalife, cannalife, kannabis, government patent on cannabinoids, cannabinoid patent, cannabinol, CBN, cannabidiol, CBD, cannabigerol, CBG, cannabichromene, CBC, tetrahydrocannabinol, tetrahydrocannabivarin, THCV, cannabicyclol, CBL, cannabivarin, CBV, cannabicitran, CBT, cannabidivarin, CBDV, cannabichromevarin, CBCV, cannabigerovarin, CBGV, cannabigerol monomethyl ether, CBGM, Arachidonoylethanolamine, AEA, anandamide, 2-arachidonoyl glycerol, 2-AG, 2-arachidonyl glyceryl ether, noladin ether, N-arachidonoyl-dopamine, NADA, virodhamine, OAE, lysophosphatidylinositol, LPI, novel therapeutics" name="keywords"
content="web" name="distribution"/

investors.kannalife.com Ip Information

Ip Country: United States
City Name: Council Bluffs
Latitude: 41.2591
Longitude: -95.8517

investors.kannalife.com Html To Plain Text

Leadership Science Investors IR Kit Tear Sheet Press Releases Stock Quotes SEC Filings Key Contacts Subscribe to Email Alerts News Contact Home About Leadership Science Investors IR Kit Tear Sheet Press Releases Stock Information SEC Filings Key Contacts Subscribe to Email Alerts News Contact Stay Ahead | | Search for: Overview Symbol NPTX Price Delayed by 20 minutes IR Nav Overview IR Kit Tear Sheet Press Releases Stock Information SEC Filings Key Contacts Subscribe to Email Alerts Tear Sheet IR Contacts Subscribe to News Alerts RSS Feed Company Profile Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown, PA 18902 (215) 695-6559 (516) 960-9212 info@kannalife.com Leadership View Management Team Recent News & Filings News View All News Articles Filings View All Filings Latest 10-K Latest 10-Q Investor Relations Investor Relations Firm CORE IR 377 Oak Street Garden City, NY 11530 (516) 222-2285 www.coreir.com Contact: John Marco Johnm@coreir.com Transfer Agent Securities Transfer Corp. 2901 Dallas Parkway, Suite 380, Plano, TX 75093 (469) 633-0101 www.stctransfer.com Auditors DBB McKennon 12790 El Camino Real #130 San Diego, CA 92130 (858) 217-4035 www.dbbmckennon.com Corporate Counsel Procopio, Cory, Hargreaves & Savitch LLP. 525 B Street, Suite 2200 San Diego, CA 92101 (619) 238-1900 www.procopio.com Click here to get the latest in Neuropathix, Inc. News Home About Leadership Science Investors IR Kit Tear Sheet Press Releases Stock Quotes SEC Filings Key Contacts Subscribe to Email Alerts News Contact Copyright © 2024 Neuropathix, Inc. All rights...

investors.kannalife.com Whois

Domain Name: KANNALIFE.COM Registry Domain ID: 1596486413_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-05-09T03:18:57Z Creation Date: 2010-05-09T18:51:51Z Registry Expiry Date: 2028-05-09T18:51:51Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS07.DOMAINCONTROL.COM Name Server: NS08.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T23:35:39Z <<<